Nima Alidoust

Discover how Tahoe Therapeutics (formerly Vevo) is generating gigascale single-cell data that map how drugs interact with cells from cancer patients. They are using that to find better therapeutics, and to build AI models that can predict drug-patient interactions on Databricks. Their technology enabled the landmark Tahoe-100M atlas, the world’s largest dataset of drug responses-profiling 100 million cells across 60,000 conditions. Learn how we use Databricks to process this massive data, enabling AI models that predict drug efficacy and resistance at the cellular level. Recognized as the Grand Prize Winner of the Databricks Generative AI Startup Challenge, Tahoe sets a new standard for scalable, data-driven drug discovery.

Hear from VC leaders, startup founders and early stage customers building on Databricks around what they are seeing in the market and how they are scaling their early stage companies on Databricks. This event is a must see for VCs, founders and those interested in the early stage company ecosystem.